| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3637 | Nfu1827 | Novel inhibitor of human cytomegalovirus (HCMV) infection |
|
| DCC3638 | Ngd 98-2 | New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist |
|
| DCC3639 | Ngd-8243 | Novel TRPV1 Antagonist |
|
| DCC3640 | Ngd9002 | New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist |
|
| DCC3641 | Ngp1-01 | Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th |
|
| DCC3642 | Nh2-bodipy | Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells |
|
| DCC3643 | Nh2-nplh2 | Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo |
|
| DCC3644 | Nh2-uamc1110 | UAMC1110 Conjugate Linker |
|
| DCC3645 | Nhi-1j | Selective Inhibitor of Human Lactate Dehydrogenase Isoform A (LDH-A) |
|
| DCC3646 | Nicodicosapent | Novel inhibitor of the sterol regulatory element binding protein (SREBP) |
|
| DCC3647 | Nicofibrate | Antilipidemic agent |
|
| DCC3648 | Nifrofam | Novel fluorescent probe for imaging α4β2* nAChRs |
|
| DCC3649 | Nik-21273 | Potent and selective NOP receptor antagonist |
|
| DCC3650 | Nim811 | Cyclophilin inhibitor, showing reduction in interleukin-2 expression and reduction in CNS inflammatory infiltrates, inhibiting HCoV-229E replication |
|
| DCC3651 | Ningetinib Tosylate | Novel potent tyrosine kinase inhibitor (TKI), targeting c-Met, VEGFR2 and Axl |
|
| DCC3652 | Niraparib R-enantiomer | Novel potent PARP1 inhibitor |
|
| DCC3653 | Nir-bg2 | Novel self-immobilizing near-infrared (NIR) fluorogenic probe that can be activated by senescence-associated ß-galactosidase (SA-ß-Gal), the most widely used senescence marker |
|
| DCC3654 | Nir-hs | Novel highly selective and sensitive near-infrared fluorescent probe for imaging of hydrogen sulphide in living cells and mice |
|
| DCC3655 | Nir-ii Fluorophore-h1 | Novel precursor of bright-emission NIR-II fluorophores for in vivo tumor imaging and image-guided surgery |
|
| DCC3656 | Nirluc2 | NIR emitting firefly luciferin analogue, displaying dose-independent improved NIR emission even at low concentrations where the native d-luciferin substrate does not emit |
|
| DCC3657 | Nir-o2 | Novel NIR NIR O2˙– probe, displays superior sensitivity to NIR O2˙– and having the capability to monitor trace amounts of intracellular NIR O2˙– in AKI in vivo |
|
| DCC3658 | Nitd008 | Antiviral agent against KFDV, AHFV, OHFV, as well as tick-borne encephalitis virus (TBEV) and mosquito-borne flaviviruses |
|
| DCC3659 | nitro-r-flurbiprofen | Selective modulator of amyloid-beta peptide degradation, regulating Abeta levels |
|
| DCC3660 | Nivocasan | Novel pan-caspase inhibitor, potently reducing not only inflammasome-mediated interleukin-1β (IL-1β) secretion but also osteoclast differentiation in BMMs |
|
| DCC3661 | Nizofenone Fumarate | Neuroprotective, protecting neurons from death following cerebral anoxia (interruption of oxygen supply to the brain). |
|
| DCC3662 | Nktr-102 | Topoisomerase I inhibitor prodrug, slowly hydrolyzing and releasing irinotecan, increasing drug penetration into tumors and decreasing drug clearance |
|
| DCC3663 | Nld-22 | Novel Enterovirus 71 Inhibitor, binding to the hydrophobic pocket in VP1 to block viral infection, exhibiting excellent antiviral activity (with an EC50 of 5.056 nM and a 100% protection rate for mice at a dose of 20 mg/kg) and low toxicity |
|
| DCC3664 | Nlrp3 Inhibitor 4b | Novel NLRP3 inhibitor, reducing caspase-1 activation, oligomerization of ASC, and therefore, IL-1β processing, showing a significant anti-inflammatory effect and reduced mechanical hyperalgesia at 3 and 10 mg/kg (i.p.) in an in vivo mouse of gout |
|
| DCC3665 | Nmac24 | Novel Nm23-H1 activator, exerting cytotoxic effects on metastatic breast cancer cells by inducing mitochondrial dysfunction only under glucose starvation |
|
| DCC3666 | nmda167-3 | Novel inhibitor of the Gli1 transcription, inducing apoptosis in cancer cells but not in non-cancerous cells |
|
